Cargando…

Congestive Heart Failure with Preserved Ejection Fraction in a Patient with Light Chain (AL) Amyloidosis and Multiple Myeloma

Patient: Male, 53 Final Diagnosis: Cardiac amyloidosis Symptoms: Dyspnea • chest pain • swelling Medication: — Clinical Procedure: Diagnostic approach Specialty: Cardiology OBJECTIVE: Challenging differential diagnosis BACKGROUND: Amyloidosis is characterized by tissue deposition of insoluble fibril...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrizales-Sepúlveda, Edgar Francisco, Ordáz-Farías, Alejandro, Vera-Pineda, Raymundo, Benavides-González, Mario Alberto, Flores-Ramírez, Ramiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519221/ https://www.ncbi.nlm.nih.gov/pubmed/28701686 http://dx.doi.org/10.12659/AJCR.904295

Ejemplares similares

Echocardiographic manifestations during the first 3 months after an episode of COVID-19 and their relationship with disease severity and persistence of symptoms
por: Vera-Pineda, Raymundo, et al.
Publicado: (2023)

Echocardiographic Manifestations in COVID-19: A Review
por: Carrizales-Sepúlveda, Edgar Francisco, et al.
Publicado: (2021)

Echocardiographic Characteristics of Subjects With COVID-19: A Case Series
por: Vera-Pineda, Raymundo, et al.
Publicado: (2020)

Energetic Basis for Exercise-Induced Pulmonary Congestion in Heart Failure With Preserved Ejection Fraction
por: Burrage, Matthew K., et al.
Publicado: (2021)

Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis
por: van den Berg, Maarten P, et al.
Publicado: (2019)

Prognostic value of left atrial mechanics in cardiac light-chain amyloidosis with preserved ejection fraction: a cohort study
por: Liu, Xiao-hang, et al.
Publicado: (2022)

Pseudomyocardial Infarction in a Patient with Severe Diabetic Ketoacidosis and Mild Hyperkalemia
por: Carrizales-Sepúlveda, Edgar Francisco, et al.
Publicado: (2019)

Right Ventricular Thrombus in Transit in a Patient With COVID-19
por: Carrizales-Sepúlveda, Edgar Francisco, et al.
Publicado: (2022)

Pioglitazone-induced congestive heart failure and pulmonary edema in a patient with preserved ejection fraction
por: Jearath, Vaneet, et al.
Publicado: (2016)

Amyloid Light-Chain Amyloidosis Manifesting as Heart Failure with Preserved Ejection Fraction in a Patient with Hyper-Immunoglobulin E-emia
por: Nojima, Yuhei, et al.
Publicado: (2016)

Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction
por: Mesquita, Evandro Tinoco, et al.
Publicado: (2017)

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Klaassen, Sebastiaan HC, et al.
Publicado: (2020)

Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan
por: Naito, Takanori, et al.
Publicado: (2023)

Transthyretin Cardiac Amyloidosis: Pathogenesis, Treatments, and Emerging Role in Heart Failure with Preserved Ejection Fraction
por: Ton, Van-Khue, et al.
Publicado: (2015)

An echo score raises the suspicion of cardiac amyloidosis in Chinese with heart failure with preserved ejection fraction
por: Yang, Hong, et al.
Publicado: (2022)

The Role of Congestion Biomarkers in Heart Failure with Reduced Ejection Fraction
por: Correale, Michele, et al.
Publicado: (2023)

Predictive Value of Assessing Diastolic Strain Rate on Survival in Cardiac Amyloidosis Patients with Preserved Ejection Fraction
por: Liu, Dan, et al.
Publicado: (2014)

Wild type transthyretin amyloidosis, a reason not to be forgotten for heart failure of preserved ejection fraction in the elderly
por: TIAN, Zhuang, et al.
Publicado: (2020)

Recurrent heart failure with preserved ejection fraction associated with carfilzomib administration for multiple myeloma
por: Yang, Eric H., et al.
Publicado: (2018)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Spontaneous Distal Biceps Tendon Rupture as a Rare Finding of Systemic Amyloidosis and Heart Failure with Preserved Ejection Fraction
por: Kocabaş, Umut, et al.
Publicado: (2020)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Value of the HFA‐PEFF and H(2)FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis
por: Tomasoni, Daniela, et al.
Publicado: (2022)

Heart Failure with Preserved Ejection Fraction – Concept, Pathophysiology, Diagnosis and Challenges for Treatment
por: Miljkovik, Lidija Veterovska, et al.
Publicado: (2015)

Suspecting Cardiac Amyloidosis in Congestive Heart Failure
por: Alatassi, Emad U, et al.
Publicado: (2020)

Rapid decline in ejection fraction and persistent elevation of troponin associated with cardiac amyloidosis
por: Abe, Temidayo, et al.
Publicado: (2020)

The Relationship between Nocturnal Hypoxemia and Left Ventricular Ejection Fraction in Congestive Heart Failure Patients
por: Mirzaaghazadeh, Mohammad, et al.
Publicado: (2014)

Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction
por: Zordoky, Beshay N., et al.
Publicado: (2015)

Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
por: Samson, Rohan, et al.
Publicado: (2016)

Animal models of heart failure with preserved ejection fraction
por: Conceição, G., et al.
Publicado: (2016)

Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016)

Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction
por: Nanayakkara, Shane, et al.
Publicado: (2018)

Modelling the complexity of heart failure with preserved ejection fraction
por: O’Gallagher, Kevin, et al.
Publicado: (2018)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i1hbcmlcaj91vs990ljhj4saar